Company intelligence / Profile preview

Shanghai Biotree Biotech

Shanghai, Shanghai, China

Ownership: Private
Development stage: Other

Overview

Over 10 years, Biotree has become a leading metabolomics service and medical device provider in China, with significant industry/university collaborations and support for published clinical/proteomic research.

Therapeutic areas: OncologyNeurologyOtherMetabolic Disorders
Industry: Metabolite Diagnostics

Partnerships

Umetrics, Sweden (data analysis)Kingmed Group (strategic partnership; clinical reference lab/diagnostics)Yangzi Scientific and Technological Innovation (joint mass spec platform)

Beyond the preview

Go deeper on Shanghai Biotree Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shanghai Biotree Biotech.

Explore the full profile